Dr. Art Tipton Joins Gannet BioChem's Board of Directors
Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO), has recently welcomed Dr. Art Tipton to its Board of Directors. This significant appointment showcases the company’s commitment to strengthening its scientific and commercial presence in the life sciences sector.
The Expertise of Dr. Art Tipton
With a rich background in science, entrepreneurship, and leadership, Dr. Tipton is no stranger to the industry. He has held pivotal roles in numerous life science enterprises, notably serving as CEO of Southern Research. Throughout his illustrious career, he has authored over 43 patents and has made impactful contributions to a variety of commercial products. Dr. Tipton currently sits on six boards and has an impressive history of service on 11 others.
A Leader in Life Sciences
Dr. Tipton's reputation as a leader in life sciences is well-established. He is a distinguished member of several prestigious organizations, including the National Academy of Engineering, the National Academy of Inventors, the Controlled Release Society College of Fellows, and the American Institute for Medical and Biological Engineering College of Fellows. His academic credentials include a Ph.D. in Polymer Science and Engineering from the University of Massachusetts.
Vision for Gannet BioChem
Nick Shackley, CEO of Gannet BioChem, emphasized the value of Dr. Tipton’s unique blend of technical and business acumen, stating, “Art’s unique combination of technical depth and business leadership will be invaluable as Gannet expands its capabilities to support partners worldwide.” His insights are expected to play a crucial role as the company continues to grow.
Dr. Tipton's Thoughts on His New Role
In his remarks about joining the board, Dr. Tipton expressed his enthusiasm: “I’m honored to join Gannet BioChem’s Board of Directors. With its strong expertise in activated polymers, notably polyethylene glycol (PEG) reagents and GMP manufacturing, the company is well-positioned to enable the next generation of therapeutics. I have been following the PEG thought-leadership stemming from Huntsville for many years, starting with Milt Harris and Shearwater Polymers; glad to see these efforts continue at Gannet.”
Engagement and Upcoming Events
Gannet BioChem, under Dr. Tipton's guidance, is set to make a significant presence at the upcoming Partnership Opportunities in Drug Delivery Conference (PODD) taking place in Boston. This event, happening on October 27–28, 2025, will provide a platform for Gannet’s leaders to highlight the company’s innovative capabilities and connect with industry peers. Interested parties can arrange meetings with the Gannet BioChem team by reaching out via email.
About Gannet BioChem
Gannet BioChem boasts over 30 years of experience as a premier specialty CDMO. The company focuses on the development and manufacturing of polyethylene glycol (PEG) reagents, which are critical components in advanced biopharmaceutical and therapeutic products. Operating from a modern 124,000 sq. ft. FDA-inspected facility, Gannet provides comprehensive GMP production services, supporting both clinical and commercial therapeutic needs. The highly experienced team at Gannet is committed to delivering innovative, quality solutions that cater to the evolving demands of the global biopharmaceutical industry.
About Ampersand Capital Partners
Ampersand Capital Partners, established in 1988, is a notable private equity firm specializing in growth-oriented investments within the healthcare sector. With a robust asset management portfolio reaching $3 billion, Ampersand operates out of hubs located in Boston, Amsterdam, and London. The firm excels in building market-leading companies through a distinctive blend of private equity and operational expertise, ensuring long-term performance alongside its management teams.
Frequently Asked Questions
Who is Dr. Art Tipton?
Dr. Art Tipton is a prominent figure in the life sciences industry with extensive experience and numerous patents to his name.
What position has Dr. Tipton recently taken?
Dr. Tipton has joined the Board of Directors at Gannet BioChem.
What is Gannet BioChem known for?
Gannet BioChem specializes in the development and manufacturing of polyethylene glycol (PEG) reagents for the biopharmaceutical sector.
Where is Gannet BioChem's facility located?
Gannet BioChem operates from a state-of-the-art, FDA-inspected facility in Huntsville, Alabama.
What is the significance of PEG in therapeutics?
PEG reagents are essential components in various therapeutic products, contributing to their efficacy and stability.
